ESC 365 - Outcomes with oral anticoagulation resumption or discontinuation after an anticoagulation-related event in patients with atrial fibrillation

ESC Professional Premium Access

Outcomes with oral anticoagulation resumption or discontinuation after an anticoagulation-related event in patients with atrial fibrillation

Session: Oral anticoagulation: minimising bleeding

Topic: Anticoagulants

Speaker: Doctor G. Denas (Motta Di Livenza, IT)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Gentian Denas

Motta di Livenza High Specialization Rehabilitation Hospital, Motta Di Livenza (Italy)

1 presentation

0 follower

5 more presentations in this session

Effectiveness of high- versus low-dose four-factor prothrombin complex concentrate on hemostasis and thromboembolism in patients with oral factor Xa inhibitor-associated intracranial hemorrhage

Speaker: Doctor W. Baker (Storrs, US)

DNA methylation of ADAMTS7 gene promoter in direct oral anticoagulant-induced bleeding in patients with atrial fibrillation

Speaker: Miss N. Atzemian (Zurich, CH)

Factor XI inhibitors in early clinical trials: a meta-analysis

Speaker: Doctor M. Galli (Rome, IT)

Detection and management of clinically relevant drug-drug interactions with direct oral anticoagulants in ambulatory care: a prospective interventional study in community pharmacies

Speaker: Mr A. Capiau (Ghent, BE)

Comparison of Antithrombotic Regimens after Left Atrial Appendage Occlusion: A Systematic Review and Network Meta-analysis

Speaker: Doctor L. KUBRUSLY (Curitiba, BR)

Access the full session

Oral anticoagulation: minimising bleeding

Speakers: Doctor G. Denas, Doctor W. Baker, Miss N. Atzemian, Doctor M. Galli, Mr A. Capiau...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources